EC approves Spinraza, Brineura

By Alicia Parker | Jun 1, 2017 | 10:27 PM GMT

The European Commission approved a pair of new drugs for rare diseases: Spinraza nusinersen from Biogen Inc. (NASDAQ:BIIB)